Chromatin Bioscience signs a Research Collaboration with Johnson & Johnson
January 20, 2025
We are thrilled to be working with Johnson & Johnson, a leader in global healthcare innovation.
In this project, we will leverage our proprietary chromatinLENS platform to drive advancements in synthetic promoter design and its applications in transformative healthcare solutions.
This collaboration underscores the growing recognition of our platform's potential to deliver precise, cell-type-selective, and durable gene expression, supporting innovative approaches in gene and cell therapies.
We are excited to embark on this journey with Johnson & Johnson and look forward to the opportunities this collaboration will bring.
Edinburgh UK, 13th January 2025.
January 29-30, 2025 | London, UK
January 20-23, 2025 | Dallas, Texas
Oct 22-25, 2024 | Rome, Italy
Award extends company's activities in AI/ML
Nov 4-6, 2024 | Stockholm, Sweden
Our New Principal Bioinformatics & AI/ML Engineer
May 7-11, 2024 | Baltimore, MD, USA
May 6-9, 2024 | San Jose, CA, USA
Our Director of Business Development
Work with Chromatin Bioscience
Contact us today to discuss how synthetic promoters could enhance your project
